ZNF488 is a zinc finger transcription factor that functions as both a transcriptional repressor in neural development and an oncogene in multiple cancers. In the nervous system, ZNF488 promotes oligodendrocyte differentiation and is downregulated in oligodendrocyte precursor cells during demyelinating diseases, contributing to failed differentiation into mature myelin-forming oligodendrocytes 1. However, ZNF488 exhibits oncogenic properties across multiple cancer types. In pancreatic cancer, it suppresses ferroptosis by directly binding to and activating the SCD1 promoter, promoting unsaturated fatty acid metabolism and supporting tumor cell survival 2. ZNF488 also activates the Akt/mTOR pathway to enhance pancreatic cancer cell invasion and migration 3. In glioblastoma, ZNF488 forms a nuclear complex with EP3 receptor to promote glioma stem-like cell self-renewal and resistance to tumor treating fields 4. Additionally, ZNF488 drives epithelial-mesenchymal transition through Wnt/β-catenin signaling in nasopharyngeal carcinoma 5 and activates MEK/ERK signaling in cervical cancer 6. High ZNF488 expression correlates with poor prognosis across multiple cancers 7, indicating its potential as both a biomarker and therapeutic target.